EIF1AX and thyroid gland undifferentiated (anaplastic) carcinoma: EIF1AX mutations are present in 11% of poorly differentiated thyroid cancers and anaplastic thyroid cancers and are almost invariably associated with oncogenic RAS mutations [42].